{{Rsnum
|rsid=739097
|Gene=MYH9
|Chromosome=22
|position=36350034
|Orientation=plus
|GMAF=0.4949
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=MYH9
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 33.0 | 43.8 | 23.2
| HCB | 3.7 | 32.6 | 63.7
| JPT | 2.7 | 22.3 | 75.0
| YRI | 39.6 | 50.7 | 9.7
| ASW | 48.1 | 35.2 | 16.7
| CHB | 3.7 | 32.6 | 63.7
| CHD | 2.8 | 20.8 | 76.4
| GIH | 14.1 | 44.4 | 41.4
| LWK | 42.1 | 45.8 | 12.1
| MEX | 44.6 | 41.1 | 14.3
| MKK | 48.4 | 43.1 | 8.5
| TSI | 37.6 | 45.5 | 16.8
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19320731
|Title=Further evidence for the involvement of MYH9 in the etiology of non-syndromic cleft lip with or without cleft palate
}}

{{PMID|18571626}} RASD2, MYH9, and CACNG2 genes at chromosome 22q12 associated with the subgroup of schizophrenia with non-deficit in sustained attention and executive function.

{{PMID|18716610|OA=1
}} Genomic screening identifies novel linkages and provides further evidence for a role of MYH9 in nonsyndromic cleft lip and palate.

{{PMID|20124285|OA=1
}} Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}